Registration for this module closes June 30. 

Live sessions will be held 8:30 a.m. - noon Pacific (11:30-3 p.m. Eastern).

This module will address two key topics that have broad implications in the design and analysis of clinical trials: the role of biomarkers as replacement endpoints, including insights about why a correlate does not a surrogate make; and the interpretability of confirmatory vs. exploratory analyses, motivating the need to recognize the goal of clinical research to determine whether, not to establish, that an experimental intervention is safe and effective.